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Open access under CC BThe genetic encoding of synthetic or ‘‘non-natural’’ amino acids promises to diversify the functions and
structures of proteins. We applied rapid codon-reassignment for creating Escherichia coli strains unable to
terminate translation at the UAG ‘‘stop’’ triplet, but efﬁciently decoding it as various tyrosine and lysine
derivatives. This complete change in the UAG meaning enabled protein synthesis with these non-natural
molecules at multiple deﬁned sites, in addition to the 20 canonical amino acids. UAG was also redeﬁned
in the E. coli BL21 strain, suitable for the large-scale production of recombinant proteins, and its cell
extract served the cell-free synthesis of an epigenetic protein, histone H4, fully acetylated at four speciﬁc
lysine sites.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Codon assignment in the genetic code is redundant. Each of the
20 canonical amino acids, except for methionine and tryptophan,
and the translation stop have more than one codon, and thus some
of the synonymous codons could be reassigned to synthetic or
‘‘non-natural’’ amino acids [1]. Although such amino acids have
been encoded genetically [2–4], their assigned codons are still rec-
ognized by the endogenous translation factors, and they retain
their original identities. This ambiguity in codon assignment has
limited the applicability of non-natural amino acids. When stop
or quadruplet codons are assigned to the molecules, their incorpo-
ration into proteins is hampered by the release factors recognizing
the stop codon, or the endogenous tRNA species reading the ﬁrst
three letters of the quadruplet codon [3,4]. Otherwise, the identical
sense codons are assigned to non-natural and canonical amino
acids [2]; the efﬁcient incorporation of the non-natural amino acid
inevitably causes the total replacement of the canonical amino acid
in recombinant proteins and the whole proteome.
We previously demonstrated the feasibility of completely reas-
signing a codon in vivo, by eliminating the endogenous factor recog-
nizing it [5]. TheamberUAGtriplet, oneof the three stop codons,wasctural Biology Center, 1-7-22
Yokoyama).
c.jp (S. Yokoyama), sakamo-
r, RIKEN Kobe Institute, 2-2-3
pan.
Y-NC-ND license.thus reassigned to canonical amino acids or even a non-naturalmol-
ecule, 3-iodo-L-tyrosine (Fig. 1A), in an Escherichia coli strain with
the knocked-out prfA gene. This gene encodes release factor 1, the
essential cellular component recognizing UAG and terminating
translation. Although the E. coli strain with the UAG reassignment
to glutamine grew almost as vigorously as the parent strain K-12
HST08, theUAG reassignment to the non-naturalmolecule seriously
reduced growth rate and poorly supported the large-scale produc-
tion of proteins with the amino acid. In the present study, we iden-
tiﬁed a key gene for enhancing the viability of UAG-reassigned E. coli
or ‘‘RFzero’’ strains. This ﬁnding helped us to redeﬁne UAG with
various non-natural amino acids in a number of E. coli strains with
diverse genetic backgrounds, and achieve large-scale protein
production with these molecules at deﬁned multiple sites.2. Materials and methods
2.1. E. coli strains and growth media
HST08 was purchased from Takara Bio (Japan). BL21(DE3) and
HMS174(DE3) were from Novagen. BW25113 was provided by the
National BioResource Project (Japan). 3-Iodo-L-tyrosine (Sigma–
Aldrich) and 4-azido-L-phenylalanine (Bachem) were dissolved in
0.2 N HCl and added to Luria–Bertani (LB) media at ﬁnal concentra-
tionsof 0.1 g/l and1 mM, respectively. Themediawere thenneutral-
ized with KOH. A 0.2-M aqueous solution of O-sulfo-L-tyrosine
(WatanabeChemical Industries, Hiroshima, Japan), a 100-mMaque-
ous solution of Ne-allyloxycarbonyl-L-lysine (AlocLys) (Bachem),
Fig. 1. UAG-codon reassignment in diverse genetic backgrounds and with various non-natural amino acids. (A) Structures of non-natural amino acids used in this study. (B)
The growth of the RFzero-iy strains derived from BW25113, HMS174(DE3), and BL21(DE3) was strictly dependent on the supplementation of 3-iodotyrosine in non-selective
media. Overnight cell cultures were diluted and spotted on LB plates in the absence (IY) and presence (IY+) of 3-iodotyrosine. The level of dilution increases from top to
bottom. (C) The growth of the RFzero strains with UAG codons completely redeﬁned with the indicated amino acids was strictly dependent on the supplementation of these
speciﬁc amino acids.
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added at ﬁnal concentrations of 10, 1, and 10 mM, respectively.
Ne-(o-azidobenzyloxycarbonyl)-L-lysine (AzZLys) (Shinsei Chemical
Co. Ltd., Osaka, Japan)was dissolved in 0.25 NHCl containing50% (v/
v) dimethyl sulfoxide to a concentration of 100 mM, and was added
to LBmedia at a ﬁnal concentration of 1 mM,whichwas neutralized
with NaOH.
2.2. Plasmids and prfA knockout
The sucB ORF engineered to end with UAA was cloned, with its
original ribosome-binding sites, downstream of the b-lactamase
(bla) gene in pBR322, for transcription from the bla promoter. To
create BAC8, the sucB ORF ending with UAA and the upstream
chloramphenicol acetyltransferase (cat) gene were cloned together
downstream of lolA in the BAC7 plasmid [5], by homologous
recombination using an RT/ET kit (Gene Bridges). sucB was
expressed from the cat promoter. Recombinants with BAC8 were
selected against chloramphenicol, at a concentration of 17 lg/ml.
The prfA knockout was performed in cells transformed with BAC8
and iodoTyrRS-MJR1-gent, which was derived from piodoTyrRS-
MJR1-kan [5] by substituting the gentamicin-resistance (gent) gene
for the kanamycin-resistance (kan) gene. A major part of prfA was
replaced with the Zeocin resistance gene in the chromosome by
homologous recombination, as described previously [5]. Cells with
knocked-out prfA were screened against Zeocin (50–75 lg/ml).
The tyrS promoter for expressing the tyrosyl-tRNA synthetase
(TyrRS) variants, and the pair of the lpppromoter and the rrnC termi-
nator for expressing UAG-decoding tRNA were cloned within
pBR322 to createpTyr. Thearchaeal TyrRS speciﬁc to3-iodotyrosine,with Arg in place of Asp286 for enhanced recognition of UAG-
decoding tRNAs [6], and theNap3 tRNATyrCUA variant [7]were cloned
into pTyr to create pIYN3. Similarly, the pairs of the 4-azidophenyl-
alanine-speciﬁc TyrRS variant and the pAzPhe1 tRNA [7] and of the
sulfotyrosine-speciﬁc TyrRS variant and the Nap3 tRNAwere cloned
in pTyr to create pAzFA1 and pSfYN3, respectively. RFzero-iy was
transformed with these three plasmids, to obtain growth curves
and to examine the growth dependence on the speciﬁc amino acids
by spottingonLBplates. pTacGST [5] carried theglutathione S-trans-
ferase (gst) gene, encoding GST with 25 extra N-terminal amino
acids, downstream of the tac promoter, and lacI or lacIq. The expres-
sionunits for the three variant-tRNApairswere cloned inpTacGST to
create pTacGST-IYN3, pTacGST-AzFA1, and pTacGST-SfYN3, respec-
tively. pTacGST-IYN3 carried lacI, while the other two carried lacIq.
RFzero-iywas transformedwith these three plasmids to incorporate
the speciﬁc amino acids into GST in response to UAG. The gst gene
was engineered to gst(3 amb) with UAG codons at positions 25,
47, and 98 (the numbering includes the extra N-terminal amino
acids) and gst(7 amb) with UAG at these three positions, besides
positions 82, 166, 180, and 188. The pPyl plasmid, a derivative of
pBR322 with kan in place of bla, carried two tandem copies of the
Methanosarcina mazei tRNAPyl gene, each with the lpp promoter
and the rrnC terminator, and the pair of the glnS´ promoter [8] and
the rrnC terminator for expressing the archaeal pyrrolysyl-tRNA
synthetase (PylRS) variants. The PylRS variants recognizing AzZLys
and AlocLys [9], and another variant speciﬁc for acetyllysine
(AcKRS-3) [10], were cloned in pPyl to create pPylAF, pPylF, and
pPylAcKR-3, respectively. RFzero-iy was transformed with these
three plasmids, to obtain growth curves and to examine the growth
dependence on the speciﬁc amino acids by spotting on LB plates.
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a fusion protein between thioredoxin (TRX) and GST with the extra
N-terminal peptide was expressed to allow the detection of the
truncated product due to aborted translation at the UAG near the
N-terminus of GST. The DNA fragment consisting of the TRX and
6 His tags was obtained from pET32b (Novagen) and cloned in
pTacGST, to create a fusion protein consisting of TRX, 6 His, and
GST in this order, downstream of the tac promoter. This fusion
gene and lacI were then moved to pACYC184 to create pACYC–
TRX–GST, which was mutagenized to introduce UAG at position
25 of GST to create pACYC–TRX–GSTam.
2.3. Cell-free protein synthesis
Cell-free coupled transcription/translation was performed
essentially as described previously [11]. M. mazei tRNAPyl was
prepared by in vitro transcription. An acetyllysine-speciﬁc variant
derived from M. mazei PylRS [12] with additional mutations (P5L,
N203T, and L301I) was overproduced in E. coli. These molecules
were added to the reaction to translate UAG to acetyllysine.
Nicotinamide and acetyllysine were added at ﬁnal concentrations
of 10 and 20 mM, respectively. A peptide tag (MKDHLIHNHHKHE-
HAHALVPRGSH) was added to the N-terminal methionine of hu-
man histone H4. The protein was produced into the insoluble
fraction, and then dissolved with 6 M guanidine hydrochloride
and subjected to successive chromatography for puriﬁcation
essentially as described [13,14].
2.4. Mass spectrometry
ESI-MS analyses were commercially performed by Mass Spec-
trometry Service, Research Resources Center, RIKEN Brain Science
Institute (Wako, Japan).3. Results and discussion
3.1. Engineering of sucB improves the growth of E. coli with UAG
reassigned to non-natural amino acid
The lethality of prfA knockout has been avoided by expressing
UAG-decoding tRNA and introducing seven essential open reading
frames (ORFs) engineered to end with another stop codon, UAA, in
place of UAG [5], as opposed to erasing more than 300 UAG codons
from the chromosome [15]. The identify of UAG corresponds to the
amino-acid speciﬁcity of the decoding tRNA; in RFzero-iy, which
translates UAG to 3-iodo-L-tyrosine, this translation relies on the
introduced archaeal pair of UAG-decoding tRNA and the tyrosyl-
tRNA synthetase (TyrRS) variant attaching 3-iodotyrosine to this
tRNA [16]. Note here that the rapid-codon reassignment left the
300 non-essential genes ending with UAG. We assumed that a
few of them might be engineered to end with UAA, like the seven
essential genes, so as to guarantee their expression and enhance
the growth of RFzero-iy. According to a comprehensive genetic
study (Genobase, http://sal.cs.purdue.edu:8097/GB7/index.jsp),
thirteen ORFs (atpE, ﬁmB, ﬂiNPQE, nanC, otsA, sucB, tatD, ubiF, ulaF,
and yajL) are contributing to vigorous growth. These genes were
engineered to end with UAA and then separately introduced into
RFzero-iy. We found that the engineered sucB signiﬁcantly im-
proved the growth of HST08-based RFzero-iy (Supplementary
Fig. S1A); sucB is involved in energy regeneration and ends with
two successive UAG codons. This ﬁnding may explain the poor
growth of RFzero-iy, which contrasted with the vigorous growth
of RFzero-q that translates UAG as glutamine. In RFzero-q, the
endogenous amber suppressor tRNAGln efﬁciently decodes UAG,
probably allowing the expression of sucB to some level, althougha C-terminal extra peptide was added to the product due to the
readthrough at UAG. On the other hand, the exogenous tRNA-TyrRS
pair speciﬁc to 3-iodotyrosine does not translate UAG as efﬁciently
as the suppressor tRNAGln, and may cause ribosome to stall at the
double UAG site, thus preventing the expression of sucB.
3.2. UAG reassignment in diverse genetic backgrounds
The ﬁnding with sucB showed that the proteome altered by the
incorporation of 3-iodotyrosine at the UAG codons, left intact at
the ends of 300 genes, can support vigorous growth of the HTS08-
based RFzero. We exploited this ﬁnding to reassign UAG in diverse
genetic backgrounds, other than that of HST08, and to various
non-natural amino acids. First, we tried to create RFzero-iy, based
on two K-12 strains [BW25113 and HMS174(DE3)] and a B strain
[BL21(DE3)], by introducing a plasmid carrying the engineered sucB
ORF, together with the previously engineered seven ORFs, and an-
other plasmid expressing the archaeal tRNA–TyrRS pair speciﬁc to
3-iodotyrosine. The prfA gene was successfully knocked out in all
of these strains, by replacing it with a marker gene in the chromo-
some (Supplementary Fig. S2). The resulting BW25113- and BL21-
based RFzero-iy strains grew nearly as fast as their prfA + parent
strains, while the HMS174-based strain grew only moderately
slower than its parent (Supplementary Fig. S1B–D). The growth of
all of these RFzero-iy strains strictly depended on the supplementa-
tion of 3-iodotyrosine in non-selectivemedia (Fig. 1B), which is con-
sistentwith the requirement of the cellular UAG-translating activity
for avoiding the lethality of prfA knockout.
3.3. UAG reassignment to various non-natural amino acids
Next, we redeﬁned UAGwith various tyrosine and lysine deriva-
tives (Fig. 1A). The archaeal TyrRS and pyrrolysyl-tRNA synthetase
(PylRS) have been engineered to attach these amino acids to
UAG-decoding tRNAs in E. coli. The TyrRS variants for 4-azidophe-
nylalanine [17] and O-sulfotyrosine [18], and the PylRS variants
for Ne-acetyllysine [10], Ne-allyloxycarbonyllysine (AlocLys) [9],
and Ne-(o-azidobenzyloxycarbonyl)-lysine (AzZLys) [9] were ex-
pressed in RFzero-iy strain, togetherwith their partner tRNA species
decoding UAG. As the endogenous system of RFzero-iy for translat-
ing UAG to 3-iodotyrosine does not work in the absence of this ami-
no acid, the introduction of another tRNA-variant pair and the
supplementation of its speciﬁc amino acid in the media should
redeﬁne UAG from 3-iodotyrosine to this amino acid. In fact, the
RFzero-iy strains harboring the tRNA-variant pairs speciﬁc to
4-azidophenylalanine, O-sulfotyrosine, and AlocLys could grow
nearly as fast as the parent BW25113 in the absence of 3-iodotyro-
sine,when the speciﬁc aminoacidswere supplemented in themedia
(Supplementary Fig. S1E and F). The other RFzero-iy strains, harbor-
ing the pairs for AzZLys and acetyllysine, grew moderately slower
than BW25113 (Supplementary Fig. S1F). The growth of the created
RFzero strains strictly depended on the supplemented, speciﬁc non-
natural amino acids (Fig. 1C), indicating that the UAG identity had
switched from
3-iodotyrosine to these amino acids. These results showed that the
rapid codon-reassignment is applicable with diverse genetic back-
grounds and various non-natural amino acids. The growth of the
UAG-reassigned strains was sufﬁciently fast for large-scale protein
production.
3.4. Protein synthesis with non-natural amino acids at multiple
deﬁned sites
To demonstrate protein synthesis with non-natural amino acids
in RFzero strains, we replaced some of the 15 tyrosine codons in
the glutathione S-transferase (GST) gene with UAG; we replaced
Fig. 2. Biosynthesis of GST variants with three and seven tyrosine derivatives. (A) The arrows indicate the positions corresponding to the full-length GST products in the gel
stained with blue dye (marked with ‘‘CBB’’) and the western-blotting (WB) using the anti-GST antibody. The wild-type gst, gst(3 amb), and gst(7 amb) genes (lanes labeled
with ‘‘WT’’, ‘‘3am’’, and ‘‘7am’’, respectively) were introduced into the indicated strains. The numbers below each lane show the estimated yields (mg/l culture). (B) ESI-MS
analyses of the wild-type GST (blue line) and its variant with seven iodotyrosines (red line) with predicted masses of 27,966.2 and 28,847.5 Da, respectively. The difference
corresponds to the mass of seven iodine atoms, less that of seven hydrogen atoms (881.3 Da).
Fig. 3. ESI-MS analyses of histones H4 with four acetyllysines at speciﬁc sites (red
line) and with no acetylation (blue line). The predicted mass for the unmodiﬁed
molecule is 14,188.8 Da, and the difference of 168.0 Da corresponds to the addition
of four acetyl groups (168.1 Da).
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protein surface by UAG, to create the gst(3 amb) and gst(7
amb) variant genes, respectively, with the remaining tyrosine
codons left intact. These variant genes were introduced into the
BW2115-based RFzero strains translating UAG to 3-iodotyrosine,
4-azidophenylalanine, and O-sulfotyrosine (RFzero-iy, -azf, and
-sfy, respectively), and were found to express the full-length prod-
ucts in all of these strains (Fig. 2A). RFzero-iy synthesized the vari-
ants with three and seven 3-iodotyrosines in almost equal
amounts as the wild-type GST; the incorporation of seven iodoty-
rosines in the gst(7 amb) product was conﬁrmed by mass
spectrometry (Fig. 2B). Although the variant yields were reduced
in RFzero-azf and RFzero-sfy, even the variant with seven O-sulfo-
tyrosines, with the lowest yield, was produced in a milligram-order
amount per liter of cell culture. The reduced yields suggested that
the rates of protein synthesis with 4-azidophenylalanine and
O-sulfotyrosine are slower than that with 3-iodotyrosine, probably
because the translation machinery or the assimilation mechanism
works on various non-natural amino acids with different efﬁcien-
cies [19]. In fact, the two tyrosine derivatives were also incorpo-
rated with signiﬁcantly lower efﬁciencies than 3-iodotyrosine in
a prfA + background (Supplementary Fig. S3). The yield of a variant
could also be reduced, if the incorporation of non-natural amino
acids at more sites increasingly destabilizes the protein.3.5. Production of histone H4 fully acetylated at four speciﬁc sites
Finally, we produced histone H4 with acetyllysines at speciﬁc
multiple sites, by taking advantage of the lineup of RFzero with di-
verse genetic backgrounds. Histone H4 has four lysines at positions
5, 8, 12 and 16 in the N-terminal peptide as the major post-trans-
lational acetylation sites. A method to synthesize homogenous his-
tones modiﬁed at certain positions will be useful for epigenetics
studies and developing therapeutic agents acting on chromatin
remodeling. Cell-free synthesis should serve this purpose well, be-
cause nicotinamide can be directly added at a high concentration
to the cell extract to prevent deacetylation, which causes heteroge-
neity. We used BL21-based RFzero-iy to prepare the cell extract,
since the BL21 extract was reportedly highly productive [11]. The
extract was dialyzed to remove 3-iodotyrosine, and then was sup-
plemented with the PylRS variant speciﬁc to acetyllysine and the
partner tRNA decoding UAG. The histone-H4 mutant gene, with
all four of the acetylation sites encoded by UAG, successfully
produced the full-length histone H4 with a yield of 0.2 mg per
ml-reaction; a mass spectrometric analysis conﬁrmed the incorpo-
ration of the four acetyllysines (Fig. 3).4. Concluding remarks
Non-natural amino acids have been genetically encoded in living
cells, with codons retaining their original identities [2–4]. This ambig-
uous codonassignmenthas limited theavailability of canonical amino
acidsor thenumberof incorporation sites for non-natural aminoacids
in one protein. The present study showed that codon reassignment,
free from these drawbacks, is a promisingmethod to synthesizemod-
iﬁed proteins. Our ﬁnding that UAG can be rapidly reassigned by
replacing it at the ends of a small number of UAG-ending ORFs, as
opposed to erasing all of the genomic UAG codons, might be helpful
for planning further reassignment of synonymous codons, to encode
a variety of non-natural amino acids in the genetic code.
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